ONA Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting the lipid metabolism to treat advanced cancer. As a spin-off of ICREA and IRB, ONA Therapeutics utilizes novel biology to design biopharmaceuticals that effectively combat advanced cancer. Their mission is to develop innovative therapies that provide hope and improve the lives of patients facing this devastating disease.

With an experienced and dedicated team, ONA Therapeutics is at the forefront of the biotech industry, constantly pushing the boundaries of scientific research and innovation. They are committed to unraveling the complexities of cancer and using that knowledge to develop groundbreaking therapies that target and disrupt the mechanisms driving cancer growth. If you're looking to get in touch, ONA Therapeutics welcomes inquiries and feedback.

They prioritize open communication and are dedicated to providing timely and informative responses to all inquiries. You can reach out to them through their website and stay up to date with the latest news and developments in the field of advanced cancer treatment